UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 499

Sortiert nach

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Clinical rheumatology, 2020-11, Vol.39 (11), p.3489-3497

2020

Volltextzugriff (PDF)

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

PloS one, 2013-04, Vol.8 (4), p.e60442-e60442

2013

Volltextzugriff (PDF)

Guidelines for management of atopic dermatitis

Journal of dermatology, 2009-10, Vol.36 (10), p.563-577

2009

Volltextzugriff (PDF)

Diagnostic criteria, severity classification and guidelines of localized scleroderma

Journal of dermatology, 2018-07, Vol.45 (7), p.755-780

2018

Volltextzugriff (PDF)

Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies

PloS one, 2016-04, Vol.11 (4), p.e0154285-e0154285

2016

Volltextzugriff (PDF)

Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis

Journal of dermatology, 2018-08, Vol.45 (8), p.881-890

2018

Volltextzugriff (PDF)

Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody

Journal of dermatology, 2021-01, Vol.48 (1), p.106-109

2021

Volltextzugriff (PDF)

Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay

Modern rheumatology, 2017-05, Vol.27 (3), p.551-552

2017

Volltextzugriff (PDF)

Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod

Scientific reports, 2019-01, Vol.9 (1), p.658-658, Article 658

2019

Volltextzugriff (PDF)

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Journal of dermatology, 2019-12, Vol.46 (12), p.1190-1196

2019

Volltextzugriff (PDF)

Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies

PloS one, 2016-05, Vol.11 (5), p.e0154746-e0154746

2016

Volltextzugriff (PDF)

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Blood, 2013-04, Vol.121 (16), p.3274-3283

2013

Volltextzugriff (PDF)

Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis

Journal of dermatology, 2020-01, Vol.47 (1), p.64-68

2020

Volltextzugriff (PDF)

Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients

Modern rheumatology, 2020-07, Vol.30 (4), p.681-686

2020

Volltextzugriff (PDF)

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells

Journal of allergy and clinical immunology, 2013-06, Vol.131 (6), p.1674-1682.e9

2013

Volltextzugriff (PDF)

Diagnostic criteria, severity classification and guidelines of systemic sclerosis

Journal of dermatology, 2018-06, Vol.45 (6), p.633-691

2018

Volltextzugriff (PDF)

Perspective to precision medicine in scleroderma

Frontiers in immunology, 2024-01, Vol.14, p.1298665-1298665

2024

Volltextzugriff (PDF)

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Journal of dermatological science, 2016-12, Vol.84 (3), p.272-281

2016

Volltextzugriff (PDF)

Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models

International journal of rheumatic diseases, 2020-02, Vol.23 (2), p.216-225

2020

Volltextzugriff (PDF)

Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines

Seminars in arthritis and rheumatism, 2012-12, Vol.42 (3), p.281-296

2012

Volltextzugriff (PDF)

A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation

Journal of allergy and clinical immunology, 2016-10, Vol.138 (4), p.1170-1182.e9

2016

Volltextzugriff (PDF)

Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study

International journal of rheumatic diseases, 2020-08, Vol.23 (9), p.1219-1225

2020

Volltextzugriff (PDF)

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

Science advances, 2018-07, Vol.4 (7), p.eaas9944-eaas9944

2018

Volltextzugriff (PDF)

A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

Journal of dermatological science, 2021-12, Vol.104 (3), p.201-209

2021

Volltextzugriff (PDF)

Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus

Journal of dermatology, 2018-08, Vol.45 (8), p.891-897

2018

Volltextzugriff (PDF)

1 – 25 von 499

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(416)

Publikationsform

Artikel
(463)
Berichte
(23)
Buchkapitel
(12)
Bücher
(1)

Sprache

Englisch
(488)
Japanisch
(118)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

Guidelines for management of atopic dermatitis

Diagnostic criteria, severity classification and guidelines of localized scleroderma

Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies

Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis

Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody

Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay

Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease

Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis

Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells

Diagnostic criteria, severity classification and guidelines of systemic sclerosis

Perspective to precision medicine in scleroderma

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models

Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines

A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation

Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus

Suchergebnisse filtern